MRP 83/-STRIP

Composition

Each Uncoated Modified Release Tablet Containes: Gliclazide IP 30 mg + Excipients q.s.

Doses

As Directed by Physician

Description

Gliclazide 30mg Tablet ER is a medicine used to treat type 2 diabetes mellitus in adults. It belongs to a group of medicines called sulfonylureas and helps control blood sugar levels in people with diabetes. This helps to prevent serious complications of diabetes like kidney damage and blindness.